The Resilience of Early-stage European Healthtech
Total funding for Pre-seed to Series B European healthtech companies grew 49% YoY from 2020 to 2021 and remained resilient in 2022 with an 8% YoY growth, reaching $4.4 billion.
Company · FR · 3 documents
Total funding for Pre-seed to Series B European healthtech companies grew 49% YoY from 2020 to 2021 and remained resilient in 2022 with an 8% YoY growth, reaching $4.4 billion.
Venture capital investment in private cloud companies in Europe and Israel reached $9-9.5bn YTD 2020, up from $7-7.5bn in 2019 YTD.
Accel evaluated 1,000 SaaS companies as part of its next generation software research.